SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Renovis RNVS
An SI Board Since March 2004
Posts SubjectMarks Bans Symbol
45 9 0 RNVS
Emcee:  mopgcw Type:  Unmoderated
GS brought public during the '04 bio rally...
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
45thanks for posting that, interesting read on the twists and turns to the bitter mopgcw-1/16/2012
44The rest of the story... On 31 May 2005, Renovis signed an agreement with Pfizerpgo-neil-1/15/2012
43BOSTON (MarketWatch) -- (snip) New York-headquartered Pfizer also said that itkeokalani'nui-10/4/2007
42FYI this is the FRX drug .... Desmoteplase Patient Recruitment for DesmoteplaseJohn McCarthy-10/27/2006
41Jeepers, how about a NTII RNVS merger. The savings would be great and the cash oSteve Lokness-10/27/2006
40I am not sure there is much here to salvage given the constraints of the real wokenhott-10/26/2006
39<<There was also no evidence of NXY-059 lowering the incidence of symptomaMiljenko Zuanic-10/26/2006
38NXY-059 Does Not Meet Efficacy Endpoints in Phase III Trial for Acute Ischemic Skenhott-10/26/2006
37My main reason for believing in this company (i do not hold stocks yet)is the CEidos-7/26/2006
36An analyst out with a sell rating today. Don't follow the company closely btuck-7/26/2006
35Anybody have any thought regarding the downside of RNVS? Looks like it is going idos-7/26/2006
34Stroke remedy showing promise SOUTH S.F. FIRM RENOVIS HOPING FOR BLOCKBUSTER DRUmopgcw-4/10/2006
33<b>NXY-059 for Acute Ischemic Stroke</b> are these results already zeta1961-2/8/2006
32Medical officer leaves for unknown reasons; wonder what it signifies, if anythintuck-11/22/2005
31Renovis Announces Pricing of Public Offering of Common Stock 8:00 AM EDT Septembmopgcw-9/26/2005
30Piper: RNVS :Robust Cerovive Data Support Bullish Outlook mopgcw-6/14/2005
29Renovis Ends Phase Ia Clinical Trial with REN-850 Monday June 13, 8:00 am ET Smopgcw-6/14/2005
28[A-425619, a Novel TRPV1 Receptor Antagonist -- Abbott] >>J Pharmacol Exptuck-6/12/2005
27GS: RNVS (IL/N): Additional data on Cerovive showed improved functional outcome mopgcw-6/1/2005
26GS: RNVS (IL/N): Pfizer collaboration on pain is positive but focus will remain mopgcw-6/1/2005
25Renovis Enters Worldwide Collaboration and License Agreement to Research, Develomopgcw-5/31/2005
24GS: Renovis, Inc. (RNVS) Healthcare RNVS (IL/N): FAQ on Cerovive; detailed data mopgcw-5/12/2005
23up $6, mkt does not seem confused...mopgcw-5/4/2005
22Cerovive results . . . a tad confusing: >>SOUTH SAN FRANCISCO, Calif.tuck-5/4/2005
21Renovis Reports First Quarter 2005 Financial Results 4:01 PM ET April 28, 2005 Rmopgcw-5/2/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):